The 4 analysts offering 12-month price forecasts for Dare Bioscience Inc have a median target of 5.00, with a high estimate of 7.50 and a low estimate of 3.00. The median estimate represents a +362.96% increase from the last price of 1.08.
Analyst Recommendations
The current consensus among 4 polled investment analysts is to Buy stock in Dare Bioscience Inc. This rating has held steady since November, when it was unchanged from a Buy rating.